Kestra Medical officer proposes $443K share sale

The securities listed also include a July 14, 2026 performance stock issuance and common-share sales between July 15 and August 17, 2026.

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. (KMTS) lists Brian Webster, identified as an officer and director, as proposing to sell 15,000 common shares through Merrill Lynch, with an approximate sale date of October 20, 2026, and an aggregate market value of $443,388.63. The securities listed also include 15,000 common shares granted to Webster on July 14, 2026, as part of the issuer’s equity compensation plan, and prior common-share sales from July 15 through August 17, 2026.

Key Figures

Proposed shares for sale: 15,000 shares Aggregate market value: $443,388.63 Shares outstanding: 59,561,795 shares +1 more

4 metrics

Proposed shares for sale 15,000 shares Common shares; approximate sale date October 20, 2026

Aggregate market value $443,388.63 For the 15,000 common shares listed for sale

Shares outstanding 59,561,795 shares Issuer share count listed with the proposed sale

Performance stock issuance 15,000 shares Granted July 14, 2026, as part of the issuer's equity compensation plan

Key Terms

Rule 144, Performance Stock Issuance, aggregate market value, issuer equity compensation plan

4 terms

Rule 144 regulatory

"the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Stock Issuance financial

"07/14/2026 | Performance Stock Issuance"

aggregate market value financial

"15000 | 443388.63"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

issuer equity compensation plan financial

"Granted as part of issuer equity compensation plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KMTS shares is Brian Webster proposing to sell?

Brian Webster lists 15,000 KMTS common shares for sale, with an aggregate market value of $443,388.63 and an approximate sale date of October 20, 2026. Merrill Lynch is named in connection with the proposed sale.

What recent KMTS share sales does Brian Webster's notice list?

The listed common-share sales are 15,000 shares on July 15, 2026; 7,857 on July 30, 2026; 8,948 on July 31, 2026; 13,017 on August 3, 2026; 51,900 on August 4, 2026; and 15,000 on August 17, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/20/2026 - 04:03 PM EDT Accepted by SEC EDGAR 10/20/2026 - 04:03 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001877188
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KESTRA MEDICAL TECHNOLOGIES, LTD.
SEC File Number	001-42549
Address of Issuer	3933 LAKE WASHINGTON BLVD NE SUITE 200 KIRKLAND WASHINGTON 98033
Phone	(425) 279-8002
Name of Person for Whose Account the Securities are To Be Sold	Webster Brian Daniel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty St New York NY 10281	15000	443388.63	59561795	10/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/14/2026	Performance Stock Issuance	KESTRA MEDICAL TECHNOLOGIES, LTD.			15000	07/14/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brian Webster 3933 LAKE WASHINGTON BLVD NE Suite 200 KIRKLAND WA 98033	Common Shares	07/15/2026	15000	336609.41
Brian Webster 3933 LAKE WASHINGTON BLVD NE Suite 200 KIRKLAND WA 98033	Common Shares	07/30/2026	7857	178531.04
Brian Webster 3933 LAKE WASHINGTON BLVD NE Suite 200 KIRKLAND WA 98033	Common Shares	07/31/2026	8948	202259.77
Brian Webster 3933 LAKE WASHINGTON BLVD NE Suite 200 KIRKLAND WA 98033	Common Shares	08/03/2026	13017	311424.12
Brian Webster 3933 LAKE WASHINGTON BLVD NE Suite 200 KIRKLAND WA 98033	Common Shares	08/04/2026	51900	1272585.45
Brian Webster 3933 LAKE WASHINGTON BLVD NE Suite 200 KIRKLAND WA 98033	Common Shares	08/17/2026	15000	412180.90

144: Remarks and Signature

Remarks
Date of Notice	10/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Brian Webster
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)